portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Industry Outlook, Reliance on Global State - Equity Research on Sinovac Biotech Ltd. and Pharmasset, Inc.
 
CreateTime:2011-09-02     Source:marketwatch Editor:lile
Text Size:       
 

HONG KONG, Sep 01, 2011 (MARKETWIRE via COMTEX) -- Today, www.WorldStreetFundamentals.com released its industry report highlighting Sinovac Biotech Ltd.  (SVA.NSDQ)and Pharmasset, Inc. (RCode:VRUS:)Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php .

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted Sinovac Biotech Ltd. as a holding company that conducts its business in China through its 71.56% majority owned subsidiary, Sinovac Beijing, its wholly owned subsidiaries, Tangshan Yian, Sinovac Biological and Sinovac Hong Kong, and its 30%-owned joint venture Sinovac Dalian. The entire report on Sinovac Biotech Ltd. /quotes/zigman/91613/quotes/nls/sva SVA -6.99% is available here: www.WorldStreetFundamentals.com/ViewFullReport.245.php .

World Street has featured Pharmasset, Inc. as a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections. The entire report on Pharmasset, Inc. /quotes/zigman/101019/quotes/nls/vrus VRUS -0.66% is available here: www.WorldStreetFundamentals.com/ViewFullReport.138.php .


Related Reports
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Industrial Enzyme Industry Report, 2014-2017
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1